Request a demo specialized to your need.
Naperville, Illinois – April 23, 2025 – Cloudbyz, a leading provider of unified eClinical solutions, today announced a strategic partnership with Noss Research Consulting LLC, a Global-based pharmacovigilance consulting firm renowned for its science-driven, patient-focused safety expertise. The partnership brings together Cloudbyz’s cloud-native Safety & Pharmacovigilance platform—built on Salesforce—with Noss Research Consulting’s deep regulatory and operational expertise to help life sciences companies optimize drug safety processes across the clinical and post-marketing continuum.
This collaboration is designed to modernize how safety data is captured, managed, and analyzed—helping organizations move faster, stay compliant, and reduce the burden of manual workflows.
Together, Cloudbyz and Noss Research Consulting will enable life sciences organizations to:
- Accelerate safety signal detection and reporting through automation and real-time analytics
- Ensure global regulatory compliance with audit-ready, end-to-end PV workflows
- Integrate pharmacovigilance seamlessly with clinical and safety operations for full visibility
- Access expert-led services for strategic PV planning and operational delivery at every stage
Built on a shared vision to reimagine pharmacovigilance as a strategic differentiator—not just a compliance requirement—the partnership will enable biopharma, medtech, and emerging biotech companies to confidently scale their safety operations.
"At Noss Research Consulting, we believe that every safety decision involves the patient. Partnering with Cloudbyz allows us to offer our clients a seamless bridge between digital capability and deep pharmacovigilance expertise” said Rebecca Noss, MSc Founder and CEO, Noss Research Consulting LLC. “Together, we’re equipping organizations to act with integrity, compliance, and intelligence, an increasingly complex regulatory landscape. We must protect patients.”
“Our alliance with Noss Research Consulting is a natural step in our mission to simplify and elevate clinical operations,” said Dinesh Kashyap, Founder & CEO of Cloudbyz. “With Cloudbyz’s scalable platform and Noss’s scientific leadership in PV, we’re helping organizations reduce risk, ensure compliance, and—most importantly—protect patient safety.”
This partnership represents a new standard in digital pharmacovigilance—one that’s proactive, data-driven, and designed to evolve with the needs of today’s global life sciences industry.
For more information about the Cloudbyz and Noss Research Consulting partnership and integrated solutions, please contact Cloudbyz or Noss Research Consulting directly.
About Cloudbyz
Cloudbyz is a leading provider of cloud-based, end-to-end eClinical solutions built on the Salesforce platform. From clinical trial management (CTMS, CTBM) to safety & pharmacovigilance and electronic data capture (EDC), Cloudbyz enables life sciences organizations to simplify clinical trials, enhance compliance, and accelerate innovation. Cloudbyz is committed to a sustainable, net-zero future.
Learn more at www.cloudbyz.com
CTMS | CTBM | eTMF | EDC | eConsent | ePRO | eCOA | RTSM | HBSM | Safety & Pharmacovigilance
About Noss Research Consulting LLC
Noss Research Consulting LLC is a Global-based pharmacovigilance consulting firm offering comprehensive safety services across the clinical development and post-marketing landscape. With deep experience across therapeutic areas and regulatory frameworks, the Noss team supports pharmaceutical, biotech, and medtech organizations in designing and executing compliant, efficient pharmacovigilance strategies.
Learn more at pvgilance.com
Press Contact:
Pooja Sood
Manager, Marketing
Cloudbyz Inc.
Phone: +1 (855)-261-6918
Email: marketing.team@cloudbyz.com
Subscribe to our Newsletter
